278 related articles for article (PubMed ID: 11097439)
21. Electronic health databases for epidemiological research on joint replacements: considerations when making cross-national comparisons.
Oleske DM; Bonafede MM; Jick S; Ji M; Hall JA
Ann Epidemiol; 2014 Sep; 24(9):660-5. PubMed ID: 25088754
[TBL] [Abstract][Full Text] [Related]
22. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
[TBL] [Abstract][Full Text] [Related]
23. Value-based Total Hip and Knee Arthroplasty: A Framework for Understanding the Literature.
Schwartz AJ; Bozic KJ; Etzioni DA
J Am Acad Orthop Surg; 2019 Jan; 27(1):1-11. PubMed ID: 30260912
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Payer Type on Patient-Reported Outcomes in Total Joint Arthroplasty Is Modulated by Baseline Patient Characteristics.
Halawi MJ; Cote MP; Savoy L; Williams VJ; Lieberman JR
J Arthroplasty; 2019 Jun; 34(6):1072-1075. PubMed ID: 30797645
[TBL] [Abstract][Full Text] [Related]
25. Cost-benefit analysis of routine pathology examination in primary shoulder arthroplasty.
Howard DR; Kazemi N; Rubenstein WJ; Hartwell MJ; Poeran J; Chang AL; Podolnick JD; Parsons BO; Galatz LM; Flatow EL
J Shoulder Elbow Surg; 2017 Apr; 26(4):674-678. PubMed ID: 28277257
[TBL] [Abstract][Full Text] [Related]
26. The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030.
Ackerman IN; Bohensky MA; Zomer E; Tacey M; Gorelik A; Brand CA; de Steiger R
BMC Musculoskelet Disord; 2019 Feb; 20(1):90. PubMed ID: 30797228
[TBL] [Abstract][Full Text] [Related]
27. The Cost of Joint Replacement: Comparing Two Approaches to Evaluating Costs of Total Hip and Knee Arthroplasty.
Palsis JA; Brehmer TS; Pellegrini VD; Drew JM; Sachs BL
J Bone Joint Surg Am; 2018 Feb; 100(4):326-333. PubMed ID: 29462036
[TBL] [Abstract][Full Text] [Related]
28. Predicting the cost-effectiveness of total hip and knee replacement: a health economic analysis.
Jenkins PJ; Clement ND; Hamilton DF; Gaston P; Patton JT; Howie CR
Bone Joint J; 2013 Jan; 95-B(1):115-21. PubMed ID: 23307684
[TBL] [Abstract][Full Text] [Related]
29. Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery.
Irisson E; Hémon Y; Pauly V; Parratte S; Argenson JN; Kerbaul F
Orthop Traumatol Surg Res; 2012 Sep; 98(5):477-83. PubMed ID: 22854336
[TBL] [Abstract][Full Text] [Related]
30. Cost Analysis of Sending Routine Pathology Specimens following Total Joint Arthroplasty in the Age of Bundled Payments.
Holbrook HS; Plate JF; Langfitt MK; Lang JE; Shields JS
Surg Technol Int; 2017 Oct; 31():182-188. PubMed ID: 29029354
[TBL] [Abstract][Full Text] [Related]
31. [Computer-assisted joint replacement surgery. Financial and clinical impact for a specialised orthopaedic hospital].
König DP; Michael JW; Eysel P; Münnich U; Lichtenstein T; Schnurr C
Z Orthop Unfall; 2009; 147(6):669-74. PubMed ID: 20183743
[TBL] [Abstract][Full Text] [Related]
32. Percent Body Fat Is More Predictive of Function After Total Joint Arthroplasty Than Body Mass Index.
Ledford CK; Millikan PD; Nickel BT; Green CL; Attarian DE; Wellman SS; Bolognesi MP; Queen RM
J Bone Joint Surg Am; 2016 May; 98(10):849-57. PubMed ID: 27194495
[TBL] [Abstract][Full Text] [Related]
33. The use of patient-reported outcome measures to guide referral for hip and knee arthroplasty.
Dakin H; Eibich P; Beard D; Gray A; Price A
Bone Joint J; 2020 Jul; 102-B(7):950-958. PubMed ID: 32600136
[TBL] [Abstract][Full Text] [Related]
34. Unsuspected Malignancies in Routine Femoral Head Histopathologic Examination During Primary Total Hip Arthroplasty: Cost-Effectiveness Analysis.
Liow MHL; Agrawal K; Anderson DW; Freiberg AA; Rubash HE; Kwon YM
J Arthroplasty; 2017 Mar; 32(3):735-742. PubMed ID: 27697361
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs.
Räsänen P; Paavolainen P; Sintonen H; Koivisto AM; Blom M; Ryynänen OP; Roine RP
Acta Orthop; 2007 Feb; 78(1):108-15. PubMed ID: 17453401
[TBL] [Abstract][Full Text] [Related]
36. Medicare Reimbursement Attributable to Periprosthetic Joint Infection Following Primary Hip and Knee Arthroplasty.
Yi SH; Baggs J; Culler SD; Berríos-Torres SI; Jernigan JA
J Arthroplasty; 2015 Jun; 30(6):931-8.e2. PubMed ID: 25727999
[TBL] [Abstract][Full Text] [Related]
37. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
38. Supervised neuromuscular exercise prior to hip and knee replacement: 12-month clinical effect and cost-utility analysis alongside a randomised controlled trial.
Fernandes L; Roos EM; Overgaard S; Villadsen A; Søgaard R
BMC Musculoskelet Disord; 2017 Jan; 18(1):5. PubMed ID: 28061841
[TBL] [Abstract][Full Text] [Related]
39. [Cost effectiveness of hip and knee arthroplasties: a two-year follow-up study].
Rissanen P; Aro S; Sintonen H; Slätis P; Paavolainen P
Duodecim; 1998; 114(6):541-9. PubMed ID: 11466917
[No Abstract] [Full Text] [Related]
40. Comparison of clinical and histologic diagnoses in 16,587 total joint arthroplasties: implications for orthopedic and pathologic practices.
DiCarlo EF; Klein MJ
Am J Clin Pathol; 2014 Jan; 141(1):111-8. PubMed ID: 24343744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
